Ranivisio

Medicinal product

(Invented) name

Ranivisio

Active substance (s)

Ranibizumabas

Strength

10 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA04, Ranibizumab

Marketing authorisation holder

Midas Pharma GmbH, Vokietija

Date of authorisation

2022-08-25

Date of renewal

Documents

RANIVISIO mokomoji medziaga pacientams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
Ranibizumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109310	95416	1095416	flakonas	0,23 ml N1		Receptinis	EU/1/22/1673/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-08-25	Registruotas